Acar, J.F., O’Brien, T., Goldstein, F. & Jones, R. 1993. The epidemiology of bacterial resistance to quinolones. Drugs. 14 suppl. 3:24-28.
Andes, D. & Craig W. 1998. In vitro activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determination. Antimicrob. Agents Chemother. 42:2375-2379.
Andes, D. & Craig W. 1998. Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy. Infect. Dis. Clin. N. Am. 112:849-860.
Animal Health Institute, USA. 1998. Antibiotics resistance back in the news. AHI Quarterly, 19: 1-4.
Ariens, E. J. 1964. The mode of action of biologically active compounds. In: Stevens G.D. Ed: Molecular Pharmacology. New York. Academic Press. Pp. 136-148.
Bergeron, M. & Oulette, M. 1998. Preventing antibiotic resistance through rapid genotypic identification of bacteria and their antibiotic resistance genes in the clinical microbiology laboratory. J. Clin. Microbiol. 36:2169-2172.
Bogaard, A., Van Mertens, P., London, N. & Stobberingh, E. 1997. High prevalence of colonization with vancomicin and pristiniamycin resistant enterococci in healthy persons and pigs in the Netherlands: is the addition of antibiotics to blame? J. Antimicrob. Chemother.40:454-456.
Bosu W., et al 1997. East African Medical Journal. 74(3):138.
Burns, J. 1995. Mechanisms of bacterial resistance. Pediatr. Clin. North America. 42:497-507.
Craig, W., Redington, J. & Ebert, S. 1991. Pharmacodynamics of amikacin in vitro and in mouse tight and lung infection. J. Antimicrob. Chemother. 27(Suppl. C):29-40.
Craig, W. 1997. Postantibiotic effects and the dosing of macrólidos, azalydes and steptogramins. In: Zinner S, Young L, Acar J, Neu H, Editors. Expanding indications for the new macrolides, azalides and streptogramins. New York, Marcel Dekker. Pp27-38.
Craig, W. 1998. Pharmacokinetic-pharmacodynamic parameters: rationale for antibiotic use in mice and men. Clin. Infect. Dis. 26:1-12.
Craig, W. 2001. Does the Dose Matter? Clin. Infect. Dis. 33(Suppl. 3):S233-237.
Dahlstrom, B., Paalzow, L. & Segre, G. 1978. Relationship between morphine pharmacokinetics and analgesia. J. Pharmacokinet. Biopharm. 6:41-53.
Davies, J. 1994. Origin, acquisition and dissemination of resistance genes. Science 264:375-382.
Tagle, H., Fleischman, R. & Musselman, A. 1950. Effect of schedule of administration on the therapeutic efficacy of penicillin. Am. J. Med. 9:280.
Errecalde, J. 1988. Bioequivalencia, Ensayos de Fármacos “in vitro” e “in vivo”. Boletín del Centro de Estudios para el Desarrollo de la Industria Químico-Farmacéutica Argentina. (29):5-10.
Errecalde, J. 1994a. Documento sobre productos genéricos. Boletín Técnico. Pfizer, Sanidad Animal. Buenos Aires, Argentina. (176):1-6.
Errecalde, J. 1994b. El uso racional de los antimicrobianos en explotaciones lecheras. Jornadas de Actualización en Lechería. Lincoln, Buenos Aires, Argentina.
Errecalde, J. 1995. Documento sobre productos genéricos (II Parte). Boletín Técnico. Pfizer Sanidad Animal. Buenos Aires. Argentina. (180):1-5.
Errecalde, J. 1996. Antimicrobianos en leche: Su importancia en Salud Pública. Boehringer Ingelheim S.A. Buenos Aires, Argentina.
Errecalde, J. 2000a. El control de puntos críticos en el tambo: ¿Una alternativa viable en nuestro medio? Segundo Curso de Actualización Profesional Fisiopatología de la Lactancia y Calidad de Leche. Universidad Nacional de La Plata, INTA y CREA. Pp 99105.
Errecalde, J. 2000b. Uso racional de antibióticos en explotaciones lecheras. Jornada de Antibióticos en Leche. Nueva Helvecia. Uruguay. Pp. 73-79.
Errecalde, J. 2001. Relation drug-host-ectoparasite. Workshop: Relationship between pharmacokinetics and anthelmintic efficacy of endectocides. XVIII Congress WAAVP, Stressa, Italy. Pp 181-182.
Errecalde, J. 2003. La elección del medicamento de calidad. Libro de resúmenes de las XIV Jornadas Ganaderas de Pergamino, Buenos Aires. Argentina. Pp. 72-76.
FAO/OIE/WHO. 2003. First Joint Expert Workshop on Non-human Antimicrobial Usage and Antimicrobial Resistance: Scientific assessment. Background Document.
FAO/FIL. 2004. Guide to good dairy farming practice. Rome.
Galdston, I. 1943. Hasta llegar a las sulfamidas. Ed. Losada, Buenos Aires.
Gilson, et. al. 1993. Assessing prescribing practice: a tanzanian example. International Journal of Health Planning and Management 8:37-58.
Goldstein, A., Aronow, L. & Kalman, S. 1974. Principles of Drug Action. Second Ed. John Wiley and Sons Eds. Pp. 82-110.
Hall, R. 1997. Mobile gene cassettes and integrons: moving antibiotic genes in Gram negative bacteria. Ciba Foundation Symposium. 207:192-205.
Hayward, C., Griffin, G. 1994. Antibiotic resistance: the current position and the molecular mechanism involved. Br. J. Hosp. Med. 52, 473-478.
Heinemann, J., Ankenbauer R. & Amabile-Cuevas C. 2000. Do antibiotics maintain antibiotic resistance? Drug Discovery Today. 5(5):195-204.
Hui, L., Li, X. & Seng, X. 1997. Patterns and determinants of use of antibiotics for acute respiratory tract infections in children in China. Paediatric Infectious Disease Journal. 16(6):560.
Holloway, K. 2000. ¿Quién contribuye al mal uso de los antimicrobianos? Boletín de Medicamentos esenciales. Organización Mundial de la Salud. (28-29):9.
Jensen, B. 1998. The impact of feed additives on the microbial ecology of the gut in young pigs. J. Anim. & Feed Sci. 7:45-64, Suppl. 1.
Kammer, R. 1982. Milestones in antimicrobial therapy. In: Morin, R., Gorman, M. Eds. Chemistry and Biology of Beta Lactam Antibiotics. Orlando, Florida: Academic Press.
Kato, I., Yokokura, T. & Nutai, M. 1985. Induction of tumoricidal peritoneal exudates cells by administration of Lactobacillus casei. International Journal of Immuno-Pharmacology. 7:103-109.
Leggett, J., Fantin, B. & Ebert, S. 1989. Comparative antibiotic dose-effect at several dosing intervals in murine pneumonia and tight infection models. J. Infect. Dis. 159:281-292.
Leggett, J., Ebert, S., Fantin, B. & Craig, W. 1991. Comparative dose-effect relationship at several dosing intervals for beta-lactams, aminoglycoside and quinolone antibiotics against Gram negative bacilli in murine thigh infection and pneumonitis models. Scand. J. Infect. Dis. (Suppl. 74):179-184.
Lorian, V. 1980. Effects of subminimum inhibitory concentrations of antibiotics on bacteria. In: Lorian Ed. Antibiotics in Laboratory Medicine. Baltimore: Williams and Wilkins. Pp. 342-408.
McDonald, L., Kuehaert, M., Trenoves, S. & Jarvis, W. 1997. Vancomycin resistant enterococci outside the health care setting: prevalence sources and public health implications. Emerg. Infect.Dis. 3:311-317.
Mestorino, O. N. 2001. Control de residuos químicos en animales productores de leche. Primeras Jornadas Técnicas de Ciencia y tecnología de Carnes y Alimentos. Montevideo, Uruguay.
O’Brien, T. 1997. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clin. Infect. Dis. 24(suppl. 1):82:88.
Odenholt-Tornquist, I., Lowdin, E., Cars, O. 1992. Post-antibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin and amikacina. Antimicrob. Agents Chemother. 36:1852-1858.
Prescott, J., Baggot, J. & Walter, R. 2002. Terapéutica Antimicrobiana en Medicina Veterinaria. Tercera Edición. Intermédica. Buenos Aires.
Quick, J., Rankin, J. & Laing, R. 1997. Managing drug supply. 2nd De Hartford CT: Kumarian Press.
Segal-Mauirer, S., Urban, C. & Rahal, J. 1996. Current perspectives in multidrug-resistant bacteria.
Sheiner, L., Stanski, D., Vozeh, S., Niller, R., Ham, J. 1979. Simultaneous modelling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clinical Pharmacology and Therapeutics. 25(3):358-371.
Shahani, K., Friend, B. & Bailey, P. 1983. Antitumour activity of fermented colostrums and milk. Journal of Food Protection, 46:385-386.
Sharpe, M., Hill, R. & Papage, S. 1973. Pathogenic lactobacilli. Journal of Medical Microbiology. 6:281-286. Epidemiology and control. Infect. Dis. Clinics of North America. 10:939-957.
Soussy, C. (1998). Susceptibility testing of quinolones and links between in vitro and in vivo resistance. Working paper 2. The use of quinolones in food animals and potential impact in human health. WHO Meeting 2-5 June 1998. Geneva, Switzerland.
Stobberingh, E. et al 1999. Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers and urban residents in the south of the Netherlands: Evidence of transmission of vancomycin resistance from animals to humans? Antimicrob. Agents. Chemother. 43, 2215-2221.
Sundin, G., Bender, C. 1996. Dissemination of the strA-strB streptomycin resistante genes ammong commensal and pathogenic bacteria from humans, animals and plants. Mol. Ecol. 5, 133-143.
Tomke, S. & Elwinger, K. 1998. Growth promotants in feeding pigs and poultry II: Mode of action of growth promotants. Annales de Zootechnie, 47:153-167.
Uppal, R. 1993. Antimicrobial use in primary health care. Journal of Clinical Epidemiology. 46(7):671.
van der Waaji, D. 1971. Colonization resistance of the digestive tract in conventional and antibiotic treated mice. J. Hydrol.69, 405-411.
Vogelman, B. & Craig W. 1986. Kinetics of antimicrobial activity. The Journal of Pediatrics. 108(2):835-840.
Vogelman, B., Gudmundsson S., Leggett J., Turnidge J., Ebert S. & Craig W. 1988. Correlating antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158:831-837.
Wagner, J. C. 1968. Kinetics of pharmacological response. Journal of Theoretical Biology. 20:173-201, 1968.
Wall, P. 1997. Epidemiological features of multidrug resistant Salmonella typhimurium DT104 in England and Wales. The medical impact of the use of antimicrobial drugs in food animals. WHO meeting 13-17 October, Berlin, Germany.
Watts, J., Yancey, R. 1994. Proceedings. National Mastitis Council Annual Meeting. Pp.14-19.
Weidermann, B. & Heisig, P. 1999. Bakterielle resistanz gegenuber chinolonen. Chemotherapie Journal 8, 99-107.
Woodnut, G. & Berry, V. 1999. Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:29-34.
Wooldridge, M. 1999. Qualitative risk assessment for antibiotic resistance. Report for EMEA. Annex IV. Case study: Salmonella typhimurium and the quinolone/fluoroquinolone class of antibiotics. pp. 38-39.
Ziv, G. 1995. Treatment of mastitis: An overview of progress during the last ten years. The 3rd International Mastitis Seminar. Session V. May 28-June 1, Tel Aviv, Israel. pp. 312.
